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The active zone protein RIM1 confers sustained activity and neurotransmitter 
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The molecular organization of presynaptic active zones (AZs) is central to 
neurotransmitter release triggered by depolarization-induced Ca
2+
 influx.  Here, 
we demonstrate a novel interaction between AZ components, RIM1 and 
voltage-dependent Ca
2+
 channels (VDCCs), that controls neurotransmitter release.  
RIM1 associates with VDCC β-subunits via its C-terminus to markedly suppress 
voltage-dependent inactivation among different neuronal VDCCs.  Consistently, 
in neuroendocrine PC12 cells, acetylcholine release is significantly potentiated by 
the full-length and C-terminal RIM1 constructs, but membrane docking of vesicles 
is enhanced only by the full-length RIM1.  The dominant negative β construct 
BADN, that disrupts the RIM1-β association, accelerates inactivation of native 
VDCC currents, and suppresses vesicle docking and acetylcholine release in PC12 
cells, and inhibits glutamate release in cultured cerebellar neurons.  Thus, RIM1 
association with β in the AZ supports release via two distinct mechanisms: 
sustaining Ca
2+
 influx through inhibition of channel inactivation; and anchoring of 




The presynaptic active zone (AZ) is the specific site for impulse-evoked exocytosis of 
neurotransmitters at synapses of the nervous system across species
1,2
.  Fine regulation 
of AZ neurotransmitter release is integral to nervous system adaptive functions 
including learning, memory, and cognition.  The molecular organization of AZs, where 
synaptic vesicles are docked in close vicinity to VDCCs at the presynaptic membrane, is 
essential for the control of neurotransmitter release triggered by depolarization-induced 
Ca
2+
 influx.  The spacing between VDCCs and vesicles influences the dynamic 
properties of synaptic transmission
3
.  However, molecular determinants that maintain 
vesicles and VDCCs within a physiologically appropriate distance have remained 
elusive.   
RIM1, originally identified as a putative effector for the synaptic vesicle protein 
Rab3 (ref. 4), is part of the RIM superfamily whose members share a common C
2
B 
domain at their C-termini
5
.  RIM1 interacts with other AZ protein components, 
including Munc13, ELKS/CAST, RIM-BP, or Liprins, to form a protein scaffold in the 
presynaptic nerve terminal
6-10
.  Mouse knockouts revealed that, in different types of 
synapses, RIM1 is essential for different forms of synaptic plasticity
9,11
.  In the 
CA1-region Schaffer-collateral excitatory synapses and in GABAergic synapses, RIM1 
maintains normal neurotransmitter release and short-term synaptic plasticity.  In 
excitatory CA3-region mossy fibre synapses and cerebellar parallel fibre synapses, 
RIM1 is necessary for presynaptic long-term synaptic plasticity.  In autapses, the RIM1 
deletion significantly reduces the readily releasable pool of vesicles, alters short-term 
plasticity and the properties of evoked asynchronous release
12
.  However, in spite of 
the progress in understanding RIM1 functions, the mechanisms by which RIM1 acts 
remain unknown.  Moreover, the physiological roles played by other RIM isoforms 
 4 
(RIM2, RIM3, and RIM4)
5
 remain unclear. 
Multiple types of VDCCs distinguished on the basis of biophysical and 
pharmacological properties coexist in neurons
13
.  High voltage-activated types of 
VDCCs essential for neurotransmitter release include N-, P/Q-, R-, and L-types
14-16
.  





, and auxiliary subunits α
2
/δ, β, and γ17.  The α
1
-subunit is encoded 
by 10 distinct genes, whose correspondence with functional types is largely 
elucidated
13,17
.  VDCC complexes are associated with presynaptic and postsynaptic 
proteins including syntaxin, SNAP-25, synaptotagmin, CASK, and Mint primarily via 




.  The β-subunit interacts with the α
1
-subunit to 
enhance functional channel trafficking to the plasma membrane
26,27
 and to modify 
multiple kinetic properties
28
; it also interacts with other proteins
29-31
.  Therefore, it is 
intriguing to investigate whether β-subunits are involved in targeting VDCC complexes 
to specific subcellular machinery at AZs for neurotransmitter release through yet 
unidentified interactions.  Here, we demonstrate a novel molecular interaction between 
RIM1 and VDCC β-subunits, both of which are essential AZ proteins.  The RIM1-β 
interaction supports the function of RIM1 in neurotransmitter release via two distinct 
mechanisms: the anchoring of neurotransmitter-containing vesicles in the vicinity of 
VDCCs; and sustaining Ca
2+





VDCC β-subunits directly interact with RIM1 
To identify β-subunit interacting proteins that regulate AZ organization, we performed 
 5 
yeast two-hybrid screening with a mouse brain complementary DNA library using the 
full length rat β
4b
-subunit as a bait.  The β
4





 have clear neurological defects suggesting that β
4
-containing 
VDCCs are physiologically significant in the brain.  Screening identified a clone 





B domain (Fig. 1a).  Subsequent two-hybrid assays using β
4b
 mutants 
revealed that residues 49-410 containing major structural motifs such as Src homology 
3 (SH3) domain, α
1
-interacting domain known as BID, and guanylate kinase (GK) 
domain, are required for the interaction of β
4b
 with the RIM1 C-terminus (Fig. 1b).  
β
2a
 also showed RIM1 interaction.  in vitro pulldown assays using GST fusion 
constructs identified the RIM1 C-terminus (1079-1463) as a major β
4
-interaction 
domain likely formed in concert by two adjacent subdomains (1079-1257 and 
1258-1463; Fig. 1c and Supplementary Fig. 1).  An in vitro binding assay using 
purified β
4
 and RIM1 recombinants revealed a dissociation constant (K
d
) of 35.1 nM for 
RIM1(1079-1463) significantly lower than 481 nM for RIM1(1079-1257) and 717 nM 
for RIM1(1258-1463) (Fig. 1d and Supplementary Fig. 2).  These results, as well as 
the successful coimmunoprecipitation of full-length RIM1 with β
4b
 (Fig. 1e), suggest a 




RIM1 physically associates with native VDCCs in the brain 
Association between native VDCCs and RIM1 was characterized biochemically using 
VDCC complexes enriched from mouse brains through microsome preparation, KCl 
wash, solubilization, heparin purification, and sucrose density gradient fractionation
25
.  





 (Fig. 2a).  Statistical analysis of cosedimentation data reveals 
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, confirming their association in the VDCC complex 
(Fig. 2b).  RIM1 sedimented in overlapping minor and major peaks: the latter 
completely overlapped with VDCC subunits, whereas the former did not cosediment 
with VDCC and likely represents a subset of RIM1 in a smaller, non-VDCC complex.  
Syntaxin, a VDCC interacting protein
18-21
, showed similar cosedimentation with RIM1.  
Immunoprecipitation analysis of heparin purified samples confirmed that the 
cosedimentation of RIM1 is due to its specific interaction with VDCC subunits (Fig. 2c).  
Anti-β
4
 antibody precipitated RIM1 from wild-type mice but not from lethargic mice 
that express truncated β
4




.  It is unlikely 
that the β
4 
isoform exclusively mediates the RIM1-VDCC association in the brain, since 
wild-type and lethargic mice were indistinguishable in the sucrose gradient profile (Fig. 
2d).  A β
4b
 fusion construct was designed as a dominant negative (beta-AID dominant 
negative (BADN)) suppressor to dissociate the activity of β-binding proteins such as 
RIM1 from the functional VDCC complex (Supplementary Fig. 3a-c).  As residues 
49-410 of the entire 519 amino acid β
4b
 sequence are required for RIM1 binding (Fig. 
1b), BADN was based upon the “full-length” β
4b
 in order to efficiently quench RIM1.  
BADN also carries the β-interacting AID region from Ca
v





.  Since the intermolecular association of BADN with VDCC α
1
 is inhibited by 
the intramolecular occlusion of the α
1
-binding site in BADN, BADN overexpression 
should deprive native β-subunits of RIM1 without affecting their association with α
1
.  
in vitro binding and coimmunoprecipitation experiments showed the ability of BADN to 
bind to RIM1 but not to the AID-containing I-II linker region of Ca
v
2.1 
(Supplementary Fig. 3d,e).  Importantly, the native RIM1-β association in partially 
purified brain VDCCs was disrupted by 8 hr coincubation with 100 nM GST fusion 




RIM1(1079-1463) rapidly decayed with the addition of excess BADN (200 nM), 
indicating that this disruption is attributable to displacement of binding partners in the 
native association (Supplementary Fig. 3f).  These results provide evidence for a 
physiological association between native RIM1 and P/Q-type VDCCs via the β-subunit 
in brain. 
 
RIM1 targets to VDCC via β-subunits at the plasma membrane 
In recombinant HEK293 cells, β
4b 
and RIM1 were concentrated at the plasma 




-subunit, whereas they were 
diffusively colocalized throughout the intracellular area in the absence of Ca
v
2.1 (Fig. 




 (ratio of the fluorescent intensity at the 
plasma membrane (PM) to that in the cytoplasm (CYT)) was 0.52 ± 0.07 and 0.48 ± 
0.07 with Ca
v





respectively.  RIM1 localization to the plasma membrane via a membrane-targeted 
β-binding domain27 comprised of CD8 and the Ca
v
2.1 I-II linker was elicited only after 
β
4b 




 was 0.29 ± 0.03 and 
0.27 ± 0.02 with β
4b
 and 0.08 ± 0.01 and 0.08 ± 0.02 without β
4b





and RIM1, respectively.  Notably, the Ca
v
2.1-mediated plasma membrane 




-mediated colocalization of RIM1 and the 
Ca
v





0.56 ± 0.11 and 0.19 ± 0.04 for β
4b 




 was 0.33 ± 




and RIM1, respectively.  Thus, the 
RIM1-β
4b 
interaction is likely to be essential for assembly of RIM1 with VDCC at the 
plasma membrane.  In cultured hippocampal neurons, RIM1 and β
4b
 both accumulated 
near presynaptic termini, in parallel with Ca
v
2.1 clustering.  These events had a 
 8 
substantially later onset than synaptogenesis shown by synapsin I clustering observed at 
8 days in vitro (DIV) (Fig. 3c,d).  Quantitative imaging demonstrated that 
overexpression of either BADN or the RIM1 C-terminus (RIM1(1079-1463)) impaired 
the Ca
v
2.1 clustering in presynaptic varicosities (Fig. 3e,f).  The coincident targeting 
of RIM1 and β
4b
, as well as the blockade of Ca
v
2.1 accumulation by quenching of RIM1 
and βs, suggests that the RIM1-β interaction regulates localization of VDCCs at the 
presynaptic membrane.  As RIM1 interacts with multiple proteins (Fig. 1a), the RIM1 
effect observed using BADN and RIM1(1079-1463) could also be attributed to the 
quenching of other RIM interactions at different subcellular locations.  However, a 
recent immunostaining study showed that the staining intensities for Ca
v
2.2 and RIM 
co-vary at a giant calyx-type synapse
34
, consistent with the idea that they are both 
components of transmitter release sites. 
 
RIM1-β interaction modulates inactivation of VDCCs 
To elucidate the functional significance of direct RIM1-β
4
 coupling, we characterized 
whole-cell Ba
2+




/δβ complexes  









2.3, and L-type Ca
v
1.2 in BHK cells.  The most prominent RIM1 effect on VDCC 
currents was observed on inactivation parameters.  Inactivation was dramatically 
decelerated in N-, P/Q-, R-, and L-type currents (Fig. 4a,b).  The same set of VDCC 
types also showed a significant depolarizing shift in the voltage dependence of 
inactivation (Fig. 4c,d).  In P/Q-type (with β
4b
), RIM1 shifted the half inactivation 
potential (V
0.5
) by +24.6 mV eliciting an inactivation curve with a component 
susceptible to inactivation induced at high voltages (V
0.5
 (vector) = –45.9 mV, V
0.5
 
(RIM1) = –21.3 mV) and a non-inactivating component (Supplementary Table 1).  In 
 9 
N- and R-types, RIM1 provoked a switch in the major phase of biphasic inactivation 
curves from low voltage-induced (V
0.5
 and ratio; –64.5 mV and 0.91 for N, and –78.2 
mV and 0.91 for R) to high voltage-induced (V
0.5
 and ratio; –20.8 mV and 0.61 for N, 
and –27.9 mV and 0.53 for R).  The L-type inactivation curve remained monophasic, 
however the non-inactivating component was significantly augmented by RIM1 (from 
0.07 to 0.25).  In P/Q-type, similar RIM1 effects on inactivation were observed with all 
other β-subunits tested (Fig. 4a,c and Supplementary Table 2).  Furthermore, the 
C-terminal truncated mutants RIM1(1079-1463) and RIM1(1258-1463), but not 
RIM1(1079-1257), successfully slowed P/Q-type (with β
1a
) current inactivation (Fig. 
4a,c and Supplementary Table 3).  After RIM1 coexpression, single-channel 
P/Q-type currents clearly demonstrated prolongation of mean time between first channel 
opening and last closing within a trace during 750-ms depolarizations to +20 mV 
without significant changes in amplitude (0.59 pA) (Fig. 4e).  This observation 
corresponds well with the whole-cell data and suggests that RIM1 predominantly 
stabilizes the non-inactivating mode
35
.  Currents evoked by trains of action potential 
(AP) waveforms, a more physiological voltage-clamp protocol used to reveal 
closed-state inactivation
36
, further support the profound suppression of 
voltage-dependent inactivation by RIM1 (Fig. 4f).  The observed effect of RIM1 on 
VDCC inactivation is attributable to its association with the β-subunit, since 
replacement of β
4




, that directly interacts 
with α
1
 but lacks the ability to bind RIM1 (Supplementary Fig. 5a,b), failed to 
significantly affect inactivation of N-type current (Supplementary Fig. 5c,d and 
Supplementary Table 4).  In addition, BADN significantly diminished the RIM1 
effect on P/Q channel inactivation (Supplementary Fig. 5e,f and Supplementary 
Table 5).   When 5 mM Ca
2+




-dependent and voltage-dependent inactivation
38
, RIM1 still exerted 
prominent suppressive effects on inactivation in P/Q-type currents expressed in 
HEK293 cells (Fig 5a,b and Supplementary Table 6).  Importantly, in rat 
pheochromocytoma PC12 neuroendocrine cells, BADN or co-application of siRNAs 
specific for suppression of RIM1 and RIM2 expression (Supplementary Fig. 7a) 
accelerated inactivation and shifted the inactivation curve toward the hyperpolarizing 
direction (Fig. 5c,d and Supplementary Table 7).  This supports a physiologically 
significant role for RIM-mediated VDCC modulation via the β-subunit.   Notably, as 
observed in RIM1-expressing cells, voltage-dependent inactivation of presynaptic 
VDCC currents at membrane potentials ≥ –40 mV was previously demonstrated
39
.  
Thus, RIM1 exerts strong suppressive effects on the kinetics and voltage dependence of 
inactivation of VDCC currents.   
RIM1 effects on other functional current parameters such as voltage dependence 
of activation, activation kinetics, and current densities at different voltages in 
current-voltage relationships, distinguish VDCCs into two different groups (Fig. 6 and 
Supplementary Table 1).  In β
4b
-expressing BHK cells, the current densities of N- 
and P/Q-types were significantly augmented by RIM1, while those of R- and L-types 
were unaffected by RIM1 (Fig. 6c,d).  In P/Q-type, RIM1(1079-1463), that binds β, 
was sufficient to enhance current density (Fig. 6c).  By contrast, activation speeds 
were significantly decelerated and activation curves were shifted toward positive 
potentials by RIM1 in R- and L-types, but not in N- and P/Q-types (Fig. 6a,b).  
Replacement of β
4b
 with other β isoforms abolished the augmentation of P/Q-type 
current densities by RIM1 (Supplementary Fig. 6a), but slowed activation speed of 
P/Q-type by RIM1 (Fig. 6b).  The RIM1 positive shift in activation curve was also 
elicited by β
2a
 in P/Q-type (Supplementary Fig. 6b).  Thus, N- and P/Q-type currents 
 11 
responded differently than R- and L-type currents to RIM1 in terms of activation 
parameters and current densities, perhaps reflecting different subcellular localizations or 
functions of these channel subsets.   
 
RIM1-β binding anchors neurotransmitter vesicles to VDCC 
We directly observed vesicles docked to the plasma membrane using evanescent wave 
microscopy, which illuminates only the subcellular area from the surface to a depth of 
less than 100 nm by total internal reflection fluorescence (TIRF).  Dense-core vesicles 
were identified by a fusion protein of neuropeptide Y (NPY) and the fluorescent protein 
Venus in PC12 cells.  The overlapping distribution of NPY-Venus, 
VAMP-DsRedmonomer, and RIM1-DsRedmonomer indicates that transmitter-filled 
synaptic vesicles are identified using fluorescent signals of NPY-Venus (Fig. 7a).  The 
co-distribution is likely specific for RIM1, since caveolin-1-EGFP failed to colocalize 
with VAMP-DsRedmonomer.  As demonstrated in Fig. 7b and 7c, the number of 
docked vesicles was increased significantly by expression of the full-length RIM1, 
whereas it was unaffected by RIM1(11-399), that forms a ternary complex with Rab3 
and Munc13 via Zn
2+
 finger critical for neurotransmitter release
40
, or by 
RIM1(400-1078).  Importantly, BADN as well as RIM1(1079-1463) significantly 
attenuated the number of docked vesicles.  These inhibitory effects of BADN and 
RIM1(1079-1463) on vesicle docking are most likely to be exerted by quenching 
endogenous full-length RIMs, or by saturating RIM1 interaction sites on VDCC β 
subunits, respectively.  The BADN effect is not due to a reduction in the densities of 
VDCCs in PC12 cells, as BADN failed to significantly affect current densities (Fig. 5c).  
Thus, the ‘full-length’ structure is likely to be essential for RIM1 to anchor 
neurotransmitter vesicles to VDCCs. 
 12 
 
RIM1-β interaction enhances neurotransimitter release 
The physiological relevance of RIM1 interactions with the VDCC complex was studied 
by assessing neurotransmitter release from PC12 cells in which diverse high 
voltage-activated VDCC types have been precisely characterized
35,41
 (Supplementary 
Fig. 7c,d).  PC12 cells were transfected with RIM1 construct cDNAs along with the 
choline acetyltransferase (ChAT) gene that synthesizes ACh for synaptic vesicles
42
.  
ACh release, triggered by Ca
2+
 influx in response to high-K
+
 (elevation of extracellular 
K
+
 concentration from 5.9 mM to 51.1 mM) membrane depolarization, was significantly 
potentiated by full-length RIM1 (Fig. 8a and Supplementary Fig. 7e).  ACh release 
was also enhanced by the Rab3-interacting N-terminal RIM1(11-399) and by the 
C-terminal RIM1(1079-1463) that maintains VDCC currents, but not by the middle 
RIM1(400-1078).  In contrast, BADN significantly suppressed ACh release.  In 
cultured cerebellar neurons, similar suppression by BADN and potentiation by the 
full-length RIM1 were observed for high-K
+
-induced glutamate release (Fig. 8b).  The 
results suggest that RIM1 potentiates neurotransmitter release through its interaction 




The present investigation reveals a novel physical association between the presynaptic 
AZ proteins RIM1 and VDCC β-subunits.  The results of yeast two-hybrid assay, in 
vitro binding assay, and coimmunoprecipitation experiments have identified a 
RIM1-VDCC complex formed by direct interaction of the β-subunit with the α
1
-subunit 
AID region and the RIM C-terminus 1079-1463 (Fig. 1).  The identification of native 
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RIM1-VDCC complexes in brain (Fig. 2), the colocalization of RIM1 with VDCC 
subunits at the plasma membrane and the presynapse, and the disruption of such 
localization and complex formation by BADN (Fig. 3) support a physiological role for 
the RIM1-β association.  Further biochemical and functional analyses (Fig. 1 and Fig. 
4) suggest that RIM1(1079-1257) and RIM1(1258-1463) are the primary β-subunit 
binding site and modulatory region, respectively, in the RIM1 protein.  While our 
experiments showed the RIM1-β
4
 interaction, RIM1 of wild-type and lethargic brains 
was indistinguishable by sucrose gradient profile (Fig. 2a,d).  It has been previously 




2.2 in the brain and properties of 
P-type currents in Purkinje neurons are indistinguishable between wild-type and 
lethargic mice
32
.   This has been attributed to the rescue of β
4







.  We expect a similar compensatory mechanism may also occur in the 
RIM1-β interaction in lethargic mice.  Therefore, the β
4 
isoform is unlikely to 
exclusively mediate the RIM1-VDCC association in the brain.   
The RIM1-β association enables RIM1 to play a dual physiological role in 
neurotransmitter release: sustaining Ca
2+
 influx through the functional regulation of 
VDCCs and anchoring vesicles to VDCCs (Supplementary Fig. 8).  Among the 
functional parameters of VDCCs, those which are related to voltage-dependent 
inactivation are most prominently modified by RIM1 through the β interaction (Fig. 4).  
Inactivation kinetics are markedly decelerated resulting in the predominance of high 
voltage inactivation and an inactivation-resistant current component in the 2-s prepulse 
protocol.  Similarly modulated inactivation properties of P/Q-type VDCC by RIM2α, 
RIM3γ, or RIM4γ (unpublished results), which all carry the C
2
B domain, suggest that 
this function is a common feature for the RIM family
5
.  Suppression by BADN of the 
RIM1-mediated inactivation in both the recombinant (Supplementary Fig. 5e,f) and 
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native VDCCs (Fig. 5c) provides evidence that RIM1 exerts observed effects through 
the RIM1-β association.  This is supported by our finding that β
4
-GK, which binds to 
α
1
 (ref. 37) but not to RIM1, failed to mediate RIM1 effects on N-type channels 
(Supplementary Fig. 5a-d).  Although detailed molecular mechanisms underlying 
inactivation are yet to be elucidated, previous mapping of the molecular determinants 
for voltage-dependent inactivation kinetics
43
 may suggest that RIM1-β complexes 
bound to the I-II linker AID further act on adjacent segment S6 of repeat I to hinder its 
conformational transition to the inactivated state.  Alternatively, RIM1 may 
immobilize the β-subunit and the process of inactivation by slowing the movement of 
the I-II loop
44,45
.  When voltage-dependent inactivation is thus suppressed, responses 
of Ca
2+
 sensors such as synaptotagmins to Ca
2+
 influx may be potentiated at 
depolarizing membrane potentials that induce voltage-dependent inactivation when 
RIM1 is absent.  Since RIM1 virtually abolished VDCC inactivation elicited by a train 
of AP waveforms (Fig. 4f), certain forms of synaptic depression via closed-state 
inactivation
36
 may be minimized by RIM1 at AZs.  The impact of the RIM1-β 
association to delay VDCC inactivation may explain recent findings using the RIM1α 
knockout mouse demonstrating that RIM1 is important for the late stage asynchronous 
neurotransmitter release whereas synaptotagmin I is involved in the earlier synchronous 
release
12
.  With P/Q- and N-type channels, the RIM1-β association significantly 
affected channel activity as well: current densities were nearly doubled by RIM (Fig. 
6c).  Thus, RIM1 can maintain and enhance depolarization-induced Ca
2+
 influx to 
support neurotransmitter release at presynaptic AZs. 
Regarding the role of RIM1 in vesicle anchoring to VDCC at the plasma 
membrane, ‘full-length’ RIM1 is required to mediate vesicle anchoring, in contrast to 
the RIM1 suppression of VDCC inactivation which only requires the RIM1 C-terminus.  
 15 
Taking into consideration the direct RIM1-Rab3 association and the regulation of 
tethering and/or priming of synaptic vesicles by Rab3 (ref. 40), it is likely that 
simultaneous interactions of RIM1 with vesicle-associated Rab3/Munc13 via the 
N-terminal Zn
2+
-finger domain and with the VDCC β-subunit via the C-terminal C
2
B 
domain underlie, at least in part, the maintenance of a close proximity between VDCCs 
and vesicles, thereby regulating the dynamic properties of synaptic transmission
3
.  
Supporting this idea, BADN and RIM1(1079-1463) significantly suppressed vesicle 
docking in PC12 cells (Fig. 7c).  In our experiments, however, RIM1 and β-subunit 
co-targeting to the presynaptic site was observed only after early synapse formation (Fig. 
3).  It is important to note that the interaction of Mint and CASK with VDCC 
α
1
-subunits via their C-termini
22,23
 may also direct channel targeting in parallel of, or 
prior to, RIM1-β-subunit complex formation.  Notably, our observation is consistent 
with a previous report
46
 stating that the loss of UNC10/RIM caused a reduction in 
membrane-contacting synaptic vesicles within 30 nm of the dense projection at 
Caenorhabditis elegans neuromuscular junctions.  Furthermore, in RIM1α-defecient 
mice, the decay of excitatory postsynaptic currents (EPSCs) during 14 Hz trains of 
presynaptic stimulation is abolished, while the rate at which the readily releasable 
vesicle pool is refilled is indistinguishable between the wild-type and RIM1α mutant 
mice
12
.  These data suggest that RIM1-mediated vesicle anchoring to VDCCs may 
enable a rapid depletion of vesicle pools such that available vesicles are exhausted 
leading to EPSC decay.  In this scenario, RIM1 knockout would minimize rapid 
vesicle release enabling the readily releasable pool to be maintained and thus prevent 
EPSC decay.  More recently, Schoch et al. have reported mice deficient in both RIM1α 
and RIM2α show lethality due to defects in Ca2+-triggered release despite normal AZ 
length and normal spontaneous neurotransmitter release
47
.  Combined, these studies 
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support our model (Supplementary Fig. 8), predicting a dual function for the RIM1-β 
interaction in neurotransmitter release by coordinating the molecular constituents and 
Ca
2+
 signaling in AZs. 
Previous reports have demonstrated the functional impact of syntaxin, 
synaptosome-associated protein (SNAP-25), and synaptotagmin on VDCCs through 





Physical association of RIM directly via the C
2
A domain with the synprint
10
 and 
indirectly via the RIM-binding protein (RIM-BP) with the α
1
 C-terminal tail have been 
also reported
48
 (Fig. 1a).  However, RIM1 regulation of VDCCs may be independent 
of the synprint- or RIM-BP-mediated association, because RIM1(1079-1463), which 
lacks both the C
2
A domain necessary for synprint binding
10
 and the PXXP motif for the 
RIM-BP binding is still sufficient to inhibit VDCC inactivation (Fig. 4a,c).  This is 
supported by our observation that BADN (Supplementary Fig. 5e,f) or replacement of 
β with β
4
-GK (Supplementary Fig. 5a-d), is sufficient to disrupt RIM1 effects on 
inactivation.  Syntaxin and SNAP-25 have been proposed to inhibit VDCC-mediated 
Ca
2+
 influx via a hyperpolarizing shift of the inactivation curve in the absence of vesicle 
docking at VDCC sites
19,21
, while our finding by contrast implies enhancement or 
maintenance of the Ca
2+
 influx via interaction with RIM1 during the docking of vesicles.  
Importantly, previous reports suggest that RIM1 is involved in the modification of the 
release apparatus at a late stage in the vesicle cycle
9
, particularly in the post-docking 
step
49







 may play primary roles, eliciting partial 
resistance to BADN suppression of vesicle docking (Fig. 7c).  Thus, the α
1 
protein 
associations and the RIM1-β association may be distinct interactions that contribute at 
different stages of vesicle cycling to control the Ca
2+ 
supply from the source, namely the 
 17 
VDCC, in addition to regulating the proximity between the Ca
2+
 source VDCC and the 
target Ca
2+ 
sensors at the presynaptic AZ.  
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Methods 
cDNA expression, cell culture, molecular modeling, recombinant proteins, infection 
with Sindbis viruses 
Methods for cDNA cloning and expression, cell culture, molecular modeling of BADN, 
preparation of GST fusion proteins and purified β
4b
-subunit recombinants, and 
preparation and infection of Sindbis viruses can be found in Supplementary Methods. 
 
Yeast two-hybrid screening and β-galactosidase assay 
Rat β
4b
-subunit (GenBank accession number XM_215742) subcloned into pGBK-T7 
was used as a bait to screen a mouse brain pACT2 library in the yeast strain AH109 
(Clontech).  1.5 x 10
6
 transformants plated to synthetic medium lacking adenine, 
histidine, leucine, and tryptophan.  His
+
 colonies were assayed for β-galactosidase 
activity by a filter assay.  Of the transformants, 103 were His
+
, of which 21 were also 
LacZ
+
.  Prey clone #2-5 encoding RIM1(1079-1463) (NM_053270) was isolated. 
 
in vitro binding of the purified proteins, GST-pulldown and coimmunoprecipitation 
experiments. 
RIM1-GST fusion proteins at various concentrations were incubated with 50 pM 
purified recombinant β
4
-subunits for 3 h at 4 °C.  Proteins were subjected to western 
blotting (WB) with the anti-β
4
 antibody raised against the peptide 
ENYHNERARKSRNRLS.  The densities of protein signals, obtained using NIH 
image under the linear relationship with the applied amount of proteins 
(Supplementary Fig. 2a), were normalized to the densities from the maximal binding.  
For pulldown assay, the cell lysate was incubated with glutathione-Sepharose beads 
bound with purified fusion proteins.  The proteins were characterized by WB with 
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anti-myc antibody (invitrogen).  For coimmunoprecipitation, the cell lysate was 
incubated with anti-FLAG M2 monoclonal antibody (Sigma), and the 
immunocomplexes were characterized by WB with anti-myc antibody.  For details, see 
Supplementary Methods. 
 
Biochemistry of native neuronal VDCC complexes 
VDCC complexes were partially purified from brains of C57BL6 mice or lethargic 
mice (B6EiC3Sn-a/A-Cacnb4
lh
/J, Jackson Laboratory) as previously reported
25
.  KCl 
washed microsomes (50 mg) were solubilized in Buffer I (for buffers, see 
Supplementary Table 8), and centrifuged at 142,000 x g for 37 min.  The supernatant 
was incubated with Heparin-agarose (Sigma); agarose was washed with Buffer II and III 
prior to elution with Buffer IV.  After elution, samples were diluted to 150 mM NaCl 
by addition of Buffer V, and concentrated using centrifugal filter devices (Millipore).  
The samples were applied to 5-40 % sucrose density gradients (Buffer VI) and were 
centrifuged at 215,000 x g for 90 min.  WB was performed using antibodies against 
RIM (BD biosciences), Ca
v
2.1 (Alamone), syntaxin (Sigma), and β
4
 (described above).  
Western blot band densities (NIH image) were normalized from 4 to 5 independent 
experiments. 
For immunoprecipitation, partially purified neuronal VDCC complexes were 
incubated with protein A-agarose coupled to anti-β
4
 or anti-RIM1 antibodies
4
.  
Immunoprecipitated proteins were subject to WB with antibodies against RIM or Ca
v
2.1.  
To disrupt the physiological association of native RIM1 with VDCC β
4
, partially 
purified VDCC complexes were incubated with 200 nM GST-BADN and 




32 h after transfection, HEK293 cells or PC12 cells were plated onto poly-L-lysine 
coated glass coverslips.  56 h after transfection, Hoechst 33342 (1 µg/ml, Dojindo) was 
added to stain nuclei.  The imaging was performed in modified Ringer’s buffer that 




, 10 glucose, 10 HEPES (pH 
7.4).  Fluorescence images were acquired with a confocal laser-scanning microscope 
(Olympus FV500).  For details, see Supplementary Methods. 
 
TIRF imaging 
PC12 cells co-transfected with 1 µg pVenus-N1-NPY and RIM1 expression plasmids at 
the equal molar quantity (5.0 µg RIM1(11-399), 5.7 µg RIM1(400-1078), 5.0 µg 
RIM1(1079-1463), or 7.5 µg RIM1) and BADN (10 µg) using OptiFect (invitrogen) 
were plated onto poly-L-lysine-coated coverslips.  PCR analysis reveals that the RIM 
plasmids are transfected at the equal level (Supplemetary Fig. 7b).  The imaging was 
performed in modified Ringer’s buffer.  Fluorescence images of NPY-Venus were 
observed at the single vesicle level using an inverted microscope (IX71, Olympus).  
Incident light for total internal reflection illumination was introduced from the high 
numerical objective lens through a single mode optical fiber.  Images were captured by 
a cooled CCD camera (EM-CCD, Hamamatsu Photonics).  Area calculations and 
counting the number of fluorescent spots were performed using Metamorph softwares 
(Molecular Devices).  The cells showing distribution of vesicles with < 10 µm2 dark 
circle area, that can be placed in between vesicles, were selected as cells with uniformly 
distributed vesicles.  10 µm2 was the maximal dark circle area in the images from 




Immunostaining of cultured hippocampal neurons 





2.1, myc-tagged RIM1, and FLAG-tagged β
4b
 were detected using a 
Zeiss LSM510META confocal microscope using a combination of antibodies: 
anti-FLAG M2 monoclonal, anti-myc polyclonal (Cell Signaling), Alexa488- and 
Alexa594-conjugated secondary antibodies (Invitrogen).  See Supplemental Methods 
for further quantification procedures. 
 
Current recordings 
Whole-cell mode of the patch-clamp technique was performed at 22-25 °C.  An 
external solution contained (in mM): 3 BaCl
2
, 155 tetraethylammonium chloride 
(TEA-Cl), 10 HEPES, 10 glucose for BHK cells; 10 BaCl
2
, 153 TEA-Cl, 10 HEPES, 10 
glucose for PC12 cells (pH 7.4).  The pipette solution contained (in mM): 95 CsOH, 
95 Aspartate, 40 CsCl, 4 MgCl
2
, 5 EGTA, 2 ATPNa
2
, 5 HEPES, 8 creatine phosphate 
(pH 7.2).  To characterize Ca
2+





, 153 TEA-Cl, 10 HEPES, 10 glucose (pH 7.4).  The pipette 
solution contained (in mM): 135 Cs-MeSO
3





10 HEPES (pH 7.2).  Single-channel currents were recorded using cell-attached patch 
mode.  The bath solution contained (in mM): 150 KCl, 5 HEPES, 0.2 EGTA, 10 
glucose (pH 7.4).  The pipette solution contained (in mM): 110 BaCl
2
 and 10 HEPES 
(pH 7.4).  750-ms voltage steps were given every 5 s from a V
h
 of –100 mV.  Details 
of current recordings and analyses including voltage dependence of inactivation and 
activation and AP train are described in Supplementary Methods. 
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Suppression of the action of endogenous RIMs using siRNAs and BADN in PC12 
cells 
The sense siRNA sequences 5’-AAGAATGGACCACAAATGCTT-3’ and 
5’-AAGGTGATTGGATGGTATAAA-3’ for rat RIM1, and 
5’-AAGGCCCAGATACTCTTAGAT-3’ and 5’-AAGAACTATCCAACATGGTAA-3’ 
for rat RIM2 were used.  Suppression of RNA expression was confirmed using 
RT-PCR analyses (Supplemetary Fig. 7a).  The cells transfected with 8.0 µg 
pCI-neo-BADN or 8.0 µg pCI-neo-RIM1 were subjected to current recordings 72-96 h 
after transfection.  For details, see Supplementary Methods.   
 
Release assay and RNA analysis in PC12 cells 
RNA expression of the α
1
-subunits, β-subunits, RIM1, or RIM2 in PC12 cells was 
determined by RT-PCR (Supplemetary Fig. 7a,c; see Supplementary Table 9 for 
primers).  ACh secretion experiments were performed as previously reported with 
slight modifications
42
.  PC12 cells were plated in poly-D-lysine-coated 35-mm dishes 
(BD bioscience) with 5 x 10
5
 cells per dish.  Cells were co-transfected with 1 µg of 
pEFmChAT encoding mouse ChAT cDNA and RIM1 plasmids at equal molar quantity 
(3.4 µg of RIM1(11-399), 3.8 µg of RIM1(400-1078), 3.4 µg of RIM1(1079-1463), or 
5.0 µg of RIM1) and BADN (10 µg) using LipofectamineTM 2000 (invitrogen).  Three 
days after transfection, ACh secretion experiments were performed.  For details, see 
Supplementary Methods. 
 
Glutamate release assay using cerebellar neuron primary cultures 
Cerebellar granular cells were plated on polyethylenimine-coated 35-mm diameter 
culture dishes (BD Falcon) at a density of 4.5–5.0 x 10
6
 cells/dish.  BADN or RIM1 
 23 
cDNAs were introduced using Sindbis viruses in cerebellar neurons.  24 h after 
infection, high-K
+




All data accumulated under each condition from at least three independent experiments 
were expressed as means ± S.E.M.  Student’s t-test, Kolmogorov-Smirnov test, or 
ANOVA followed by Fisher’s test was employed. 
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Figure legend 
Figure 1  Direct interaction of RIM1 with the VDCC β
4b
-subunit.  
(a) Domain structure of mouse RIM1.  Arrows indicate molecules interacting with 
RIM1 at the Zn
2+
-finger like domain (Zn
2+







B); proline-rich region (PXXP)
4,6-10
.  The protein region encoded 
by clone #2-5 is also indicated.  (b) Mapping of RIM1 binding sites on β
4b
 by the yeast 
two-hybrid assay.  β-subunit constructs in bait vectors are tested with RIM1 in the prey 
vector.  The interactions are scored by β-galactosidase activity and His+ prototrophy.  
(c) Pulldown assay of β
4b
 with GST fusion RIM1 mutants.  GST fusion proteins 
immobilized on glutathione-Sepharose beads are incubated with cell lysate obtained 
from myc-β
4b
-transfected HEK293 cells.  Bound proteins are analyzed by western 
blotting (WB) using anti-myc antibody.  (d) in vitro association between the purified 
GST-RIM1 fusion constructs and recombinant β
4
-subunit (47-475).  GST-RIM1 
proteins at various concentrations, incubated with β
4
 (50 pM), are captured by 
glutathione-Sepharose beads.  Captured β
4
 proteins are examined by WB.  The 
bottom panel shows the quantitative densitometric analysis of bands shown in the upper 
panel and in Supplementary Fig. 2.  The saturation curves are subjected to the 
nonlinear least-squares curve-fitting method to evaluate the apparent dissociation 
constant (K
d
).  (e) Interaction of recombinant β
4b
 and RIM1 in HEK293 cells.  The 
interaction is evaluated by immunoprecipitation (IP) with anti-FLAG antibody, followed 
by WB with anti-myc antibody.  Top: physical association of myc-β
4b
 with 
FLAG-RIM1 in comparison to a positive control FLAG-Ca
v
2.1(I-II linker).  Bottom: 
physical association of FLAG-β
4b
 with myc-RIM1. 
 
Figure 2  Association of RIM1 with native neuronal VDCC complexes. 
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(a) Sucrose gradient fractionation of neuronal VDCC complexes from wild-type (WT) 










, and RIM1 from western blots of sucrose gradient fractions.  The 
normalized density of each protein is plotted as a function of the sucrose density 
fraction number.  (c) Coimmunoprecipitation of RIM1 with the β
4
-subunit.  
Immunoprecipitation (IP) using an anti-β
4
 antibody and subsequent WB for RIM1 is 
performed on heparin purified samples.  As a negative control, a preparation from 
lethargic mice is used.  (d) Sucrose gradient fractionation of neuronal VDCC 
complexes from lethargic mouse brains.  (e) Coimmunoprecipitation of Ca
v
2.1 with 
RIM1.  The immunocomplexes are disrupted by GST-BADN or 
GST-RIM1(1079-1463).  IP using anti-RIM1 antibody and subsequent WB for Ca
v
2.1 
is performed.    
 
Figure 3  RIM1 clusters with the VDCC subunits near presynaptic termini in 
cultured hippocampal neurons. 
(a) Ca
v
2.1 elicits plasma membrane (PM) colocalization of β
4b
 with RIM1.  BADN 
disrupts colocalization.  Left: confocal imaging of HEK293 cells expressing EGFP-β
4b
 




2.1 plus BADN.  Scale bar: 5 
µm.  Nuclei are stained with Hoechst 33342.  Right: subcellular location of EGFP-β
4b
 
or RIM1-DsRedmonomer in 1 µm widths PM region and in the cytosolic area (CYT) (n 
= 5).  
***
P < 0.001 vs vector.  
##
P < 0.01 vs Ca
v
2.1.  (b) β
4b
 elicits PM colocalization 
of Ca
v
2.1(I-II linker) and RIM1.  BADN disrupts colocalization.  Left: confocal 
imaging of HEK293 cells expressing CD8-Ca
v
2.1(I-II linker)-EGFP and 








2.1(I-II linker)-EGFP or RIM1-DsRedmonomer (n = 5).  
***
P < 0.001 vs 
vector.  
##
P < 0.01 vs β
4b
.  (c) Immunolocalization of tagged-RIM1 and β
4b
 in 
cultured hippocampal neurons.  Clustering of RIM1 and β
4b
 is undetected at 8 DIV, but 
present at a substantially later stage at 23 DIV.  Scale bar: 10 µm.  (d) Late clustering 
of EGFP-Ca
v
2.1 (arrowheads) in hippocampal neurons.  Synapsin I-positive puncta are 
already abundant at 8 DIV, while Ca
v





2.1 clusters much later on.  (e, f) Accumulation of EGFP-Ca
v
2.1 (arrowheads) 
in presynaptic varicosities is achieved between 9 and 22 DIV.  This maturation process 
is impaired by RIM1(1079-1463) or BADN, suggesting that the local VDCC 
concentration at AZs is influenced by RIM1-β-subunit interaction during a 
postsynaptogenic maturation period. 
 
Figure 4  Effects of RIM1 on the inactivation properties of recombinant neuronal 
VDCCs. 
(a) Inactivation of P/Q-type Ca
v
2.1 currents in BHK cells.  The peak amplitudes before 
and after coexpression of RIM1 constructs are normalized for Ba
2+
 currents elicited by 
2-s pulses to 0 mV from a holding potential (V
h





2.3, or L-type Ca
v
1.2 currents (with β
4b
).  The V
h





1.2) or –110 mV (Ca
v





).  Right: inactivation curves for Ca
v
2.1 in BHK cells expressing α
2
/δ and 
different β-subunits.  See Supplementary Table 2 and 3 for statistical significance of 









).  See Supplementary Table 1 for statistical significance of the differences.  
(e) RIM1 prolongs the time between first channel opening and last closing within a 




).  Seven consecutive unitary traces are shown.  
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The mean values for the time of each trace are 184.2 ± 33.3 ms (n = 117 traces) for 
vector and 502.8 ± 33.3 ms, (n = 101) for RIM1.  The time for traces without opening 
is counted as 0 ms.  (f) Left: Ca
v
2.1 currents (with β
1a
) induced by 100 Hz AP trains 
for 1 s.  Right: percentage of currents in response to the last stimulus compared to the 
peak current (n = 6 for vector and n = 4 for RIM1).  
***
P < 0.001. 
 
Figure 5  Physiological relevance of effects of RIM1 on inactivation properties of 
VDCCs. 






 currents  
(with β
1
) in HEK293 cells.  The peak amplitudes before and after RIM1 coexpression 




 currents elicited by 2-s pulses to 0 and 10 mV, 
respectively, from a V
h









) in HEK293 cells.  See Supplementary Table 6 for statistical 
significance of the differences.  (c) Effects of RIM1 and BADN on the inactivation 
properties of native VDCCs in PC12 cells (7-9 culture passage).  Left: normalized 
current traces.  Middle: inactivation curves induced by 2-s holding potential 
displacement.  See Supplementary Table 7 for statistical significance of the 
differences.  Right: comparison of current densities at 10 mV (n = 18, 15, and 9 cells 
for vector, RIM1, and BADN, respectively).   (d) Acceleration of inactivation by 
coapplication of siRNAs specific for RIM1 and RIM2 (siRIM1 and siRIM2) in VDCC 
currents recorded from PC12 cells (2-3 culture passages).  Left: normalized current 
traces.  Middle: inactivation curves.  See Supplementary Table 7 for statistical 
significance of the differences.  Right: comparison of current densities at 10 mV (n = 6 
and 8 cells, for siControl and siRIM1 and siRIM2, respectively).   
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Figure 6  Effects of RIM1 on the activation properties of VDCCs. 
(a) Effects of RIM1 on activation curves of Ca
v
 currents (with β
4b
) elicited in BHK cells.  
Tail currents elicited by repolarization to –60 mV after 5-ms test pulse from –50 to 50 
mV are used to determine activation curves.  See Supplementary Table 1 for 
statistical significance of the differences.  (b) Left: effects on activation speed of 
Ca
v
2.1 channels containing various β-subunits.  Time constants are obtained by fitting 
the activation phase of currents elicited by 5-ms test pulse to 20 mV with a single 
exponential function.  Right: effects of RIM1 on activation speed of Ca
v
 currents at 20 
mV in various VDCC types.  
*
P < 0.05 and 
***
P < 0.001.  (c) Effects of RIM1 
proteins on P/Q-type Ca
v
2.1.  Left: representative traces for Ba
2+
 currents (with β
4b
) 
upon application of test pluses from –40 mV to 50 mV with 10-mV increments.  Right: 
current density-voltage (I-V) relationships of Ca
v
2.1.  The V
h
 is –100 mV.  See 
Supplementary Table 2 for statistical significance of the differences.  (d) I-V 
relationships of Ca
v




1.2 (right) (with β
4b
).  The V
h





1.2) or –110 mV (Ca
v
2.3).  See Supplementary Table 1 for statistical 
significance of the differences.   
 
 
Figure 7  RIM1 and β-subunits associate to anchor neurotransmitter vesicles to 
VDCCs at the plasma membrane. 
(a) NPY-containing secretory vesicles are colocalized with RIM1 and VAMP, that is not 
colocalized with caveolin-1 in PC12 cells.  NPY-Venus and RIM1-DsRedmonomer, 
VAMP-Venus and RIM1-DsRedmonomer, NPY-Venus and VAMP-DsRedmonomer, or 
caveolin-1-EGFP and VAMP-DsRedmonomer are coexpressed in PC12 cells, and live 
images of the cells are obtained by confocal microscopy.  Scale bar: 10 µm.  (b,c) 
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Effects of RIM1 constructs and BADN on the density of docked vesicles.  In b, typical 
TIRF images of plasma membrane-docked vesicles containing NPY-Venus.  Left: 
BADN-co-transfected PC12 cell.  Middle: vector-co-transfected PC12 cell.  Right: 
RIM1-co-transfected PC12 cell.  Scale bar: 10 µm.  In c, the vesicle density is 
determined by counting the vesicles in each image (n = 20 cells in each).  
*
P < 0.05, 
***
P < 0.001 vs vector.  
###
P < 0.001 vs RIM1. 
 
Figure 8  The RIM1-β association enhances neurotransmitter release in PC12 
cells and cultured cerebellar neurons. 
(a) Effects of RIM1 constructs and BADN on depolarization-dependent release of ACh 
from ChAT-co-transfected PC12 cells.  Three days after transfection, PC12 cells were 
incubated for 30 s with the low-K
+
 solution (5.9 mM K
+
) at 37 °C.  The release of ACh 
during this period was considered as basal release.  To measure ACh release, the cells 
were then incubated for 30 s with a high-K
+
 solution (51.1 mM K
+
).  The amount of 
secreted ACh is determined as a percentage of the cellular content for each dish.  
***
P 
< 0.001 vs vector.  
##
P < 0.01, 
###
P < 0.001 vs RIM1.  (b) Effects of RIM1 and 
BADN on depolarization-dependent release of glutamate from cultured cerebellar 
neurons.  24 h after the introduction of cDNAs, cerebellar neurons (9–11 DIV) were 
incubated for 1 min with the low-K
+ 
solution (5.9 mM K
+
) at 37 °C.  The release of 
glutamate during this period was considered as basal release.  To measure glutamate 
release, the cells were then incubated for 1 min with a high-K
+
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